FDA approves first treatment for inherited rare disease
The approval of the drug, Givlaari was based on the results of a clinical trial of 94 patients with acute hepatic porphyria
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.